Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Investment analysts at Alliance Global Partners decreased their FY2024 EPS estimates for Curaleaf in a report issued on Wednesday, October 30th. Alliance Global Partners analyst A. Grey now expects that the company will earn ($0.27) per share for the year, down from their prior forecast of ($0.26). The consensus estimate for Curaleaf’s current full-year earnings is ($0.24) per share. Alliance Global Partners also issued estimates for Curaleaf’s Q4 2024 earnings at ($0.07) EPS, Q1 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.21) EPS.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). The firm had revenue of $342.29 million for the quarter, compared to the consensus estimate of $344.57 million. Curaleaf had a negative return on equity of 14.75% and a negative net margin of 18.59%.
Read Our Latest Research Report on CURLF
Curaleaf Stock Up 2.4 %
OTCMKTS CURLF opened at $2.96 on Friday. The business has a fifty day moving average price of $3.01 and a two-hundred day moving average price of $3.89. The stock has a market capitalization of $1.92 billion, a PE ratio of -8.46 and a beta of 0.84. Curaleaf has a fifty-two week low of $2.70 and a fifty-two week high of $6.40. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.09 and a quick ratio of 0.50.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Articles
- Five stocks we like better than Curaleaf
- 5 Top Rated Dividend Stocks to Consider
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- There Are Different Types of Stock To Invest In
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.